Sectoral Asset Management as of Sept. 30, 2016
Portfolio Holdings for Sectoral Asset Management
Sectoral Asset Management holds 56 positions in its portfolio as reported in the September 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Merck & Co (MRK) | 5.7 | $58M | 925k | 62.41 | |
| Pfizer (PFE) | 5.6 | $57M | 1.7M | 33.87 | |
| Celgene Corporation | 5.0 | $50M | 482k | 104.53 | |
| Eli Lilly & Co. (LLY) | 4.8 | $49M | 607k | 80.26 | |
| Medtronic (MDT) | 4.4 | $45M | 521k | 86.40 | |
| Gilead Sciences (GILD) | 4.1 | $42M | 524k | 79.12 | |
| Neurocrine Biosciences (NBIX) | 4.0 | $41M | 803k | 50.64 | |
| BioMarin Pharmaceutical (BMRN) | 3.7 | $38M | 411k | 92.52 | |
| Abiomed | 3.2 | $33M | 254k | 128.58 | |
| Shire | 3.2 | $32M | 166k | 193.86 | |
| Portola Pharmaceuticals | 3.2 | $32M | 1.4M | 22.71 | |
| Amicus Therapeutics (FOLD) | 3.0 | $31M | 4.2M | 7.40 | |
| NxStage Medical | 2.9 | $30M | 1.2M | 24.99 | |
| Acadia Healthcare (ACHC) | 2.8 | $29M | 577k | 49.55 | |
| Dex (DXCM) | 2.8 | $28M | 322k | 87.66 | |
| Teladoc (TDOC) | 2.8 | $28M | 1.5M | 18.31 | |
| CIGNA Corporation | 2.8 | $28M | 215k | 130.32 | |
| Global Blood Therapeutics In | 2.3 | $24M | 1.0M | 23.05 | |
| Align Technology (ALGN) | 2.2 | $23M | 243k | 93.75 | |
| Incyte Corporation (INCY) | 2.1 | $21M | 224k | 94.29 | |
| Teva Pharmaceutical Industries (TEVA) | 2.0 | $21M | 454k | 46.01 | |
| Intuitive Surgical (ISRG) | 2.0 | $21M | 28k | 724.84 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 1.9 | $19M | 218k | 87.21 | |
| Novo Nordisk A/S (NVO) | 1.8 | $19M | 445k | 41.59 | |
| Ophthotech | 1.8 | $18M | 389k | 46.13 | |
| Alder Biopharmaceuticals | 1.7 | $18M | 537k | 32.77 | |
| Acceleron Pharma | 1.7 | $17M | 482k | 36.19 | |
| Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 1.3 | $14M | 706k | 19.26 | |
| Wright Medical Group Nv | 1.2 | $12M | 505k | 24.53 | |
| NuVasive | 1.2 | $12M | 180k | 66.66 | |
| Accuray Incorporated (ARAY) | 1.2 | $12M | 1.9M | 6.37 | |
| Intercept Pharmaceuticals In | 1.1 | $12M | 71k | 164.58 | |
| Ptc Therapeutics I (PTCT) | 1.1 | $11M | 780k | 14.01 | |
| Aerie Pharmaceuticals | 0.9 | $9.4M | 249k | 37.74 | |
| Molina Healthcare (MOH) | 0.9 | $8.9M | 153k | 58.32 | |
| Prothena (PRTA) | 0.7 | $7.4M | 124k | 59.97 | |
| AmSurg | 0.6 | $6.5M | 97k | 67.05 | |
| Kite Pharma | 0.6 | $6.5M | 116k | 55.86 | |
| Team Health Holdings | 0.6 | $6.0M | 186k | 32.56 | |
| Avexis | 0.6 | $6.0M | 147k | 41.21 | |
| Integra LifeSciences Holdings (IART) | 0.6 | $5.7M | 69k | 82.54 | |
| Surgical Care Affiliates | 0.5 | $4.8M | 98k | 48.76 | |
| Advaxis | 0.5 | $4.7M | 437k | 10.69 | |
| Momenta Pharmaceuticals | 0.4 | $4.1M | 355k | 11.69 | |
| Regenxbio Inc equity us cm (RGNX) | 0.3 | $3.2M | 244k | 13.22 | |
| Neuroderm Ltd F | 0.3 | $3.0M | 162k | 18.49 | |
| Entellus Medical Cm | 0.3 | $3.0M | 134k | 22.18 | |
| Agios Pharmaceuticals (AGIO) | 0.3 | $2.8M | 53k | 52.83 | |
| Intersect Ent | 0.3 | $2.7M | 168k | 15.84 | |
| Lannett Company | 0.2 | $2.3M | 88k | 26.57 | |
| Intellia Therapeutics (NTLA) | 0.2 | $2.3M | 123k | 18.84 | |
| Alnylam Pharmaceuticals (ALNY) | 0.2 | $1.7M | 26k | 67.79 | |
| ACADIA Pharmaceuticals (ACAD) | 0.2 | $1.8M | 56k | 31.81 | |
| Dr. Reddy's Laboratories (RDY) | 0.1 | $1.5M | 32k | 46.43 | |
| Dbv Technologies S A (DBVT) | 0.1 | $1.4M | 39k | 36.33 | |
| Pronai Therapeutics | 0.0 | $399k | 202k | 1.98 |
